Apellis’ Empaveli Data In Frontline PNH Incremental, But Still Helpful
Data Could Aid Uptake Despite Already Broad Label
While the drug appears more efficacious than Alexion’s C5 inhibitors, those drugs could prove difficult to dethrone given how entrenched they are in PNH therapy.
